Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Share News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Immunodiagnostic Expects Further Revenue Fall In Current Year

Fri, 29th May 2015 06:58

LONDON (Alliance News) - Immunodiagnostic Systems Holdings PLC said Friday it expects revenue to continue to fall in its current year, and revenue in its recently ended financial year to be in line with previous guidance.

The company, which provides clinical laboratory diagnostic services, expects to post revenue of GBP45 million for the year to end-March 2015, compared to GBP52 million a year before. This is in line with guidance it provided in April. At the time, it attributed the decline to a lower level of its instruments being placed with end customers by distributors.

It expects revenue to fall further in its current year to end-March 2016 to a range between GBP39 million and GBP42 million.

Immunodiagnostic will announce its final results June 23. It said it remains committed to executing its strategic plan, and will provide further updates on its strategic objectives with its full year results.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
5 Oct 2009 13:45

London afternoon: Footsie eases into the red

The Footsie dipped into the red over the lunch-time session but it was a very shallow dip, with leading shares mixed and mostly sticking close to overnight levels. Life insurer Aviva is the heaviest faller in the FTSE 100 after it confirmed it is to sell a minority stake in its Dutch insurance bus

Read more
5 Oct 2009 12:21

Sales surge at Immunodiagnostic Systems

Diagnostics testing kit firm Immunodiagnostic Systems (IDH) enjoyed a 56% jump in revenue during the six months to September and is confident about prospects. Turnover from continuing operations jumped to £16.9m from £10.8m a year earlier. That's also 20% ahead of the second half of 2008 on a like-

Read more
29 Jun 2009 17:11

Tullett Prebon chief exec spends £1.1m

Tullett Prebon's chief executive Terry Smith has spent more than £1m upping his stake in the interdealer broker. He bought 439,731 shares at 267p a time and now has about 9.2m, which is 4.3% of the firm. He was joined by finance director Paul Mainwaring who took 103,683 shares at 268.9p a time. T

Read more
22 Jun 2009 12:56

Broker tips: Kewill, Immunodiagnostic

Strong full year results from in-vitro diagnostics group Immunodiagnostic Systems (IDH) have prompted stockbroker KBC Peel Hunt to consider raising its price target for the stock, which currently stands at 260p, not far above the prevailing market price. "Finals show revenue up to £25m (up 51%) dri

Read more
22 Jun 2009 12:55

Broker snap: Vitamin D market to lift Immunodiagnostic

Strong full year results from in-vitro diagnostics group Immunodiagnostic Systems (IDH) have prompted stockbroker KBC Peel Hunt to consider raising its price target for the stock, which currently stands at 260p, not far above the prevailing market price. "Finals show revenue up to £25m (up 51%) dri

Read more
22 Jun 2009 09:09

Small caps round-up: Imagination, Cashbox, Capital & Regional...

System on a chip technology firm Imagination Technologies Group has signed a multi-use licence agreement with semiconductor company MediaTek. MediaTek will deploy Imagination's POWERVR SGX graphics processor technology on its future system on a chip devices. Imagination will receive licensing fees

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.